Results 51 to 60 of about 162,947 (233)
Effect of amikacin, cephalothin, clindamycin and vancomycin on in vitro fibroblast growth
The effect of four antibiotics (amikacin, clindamycin, cephalothin and vancomycin) was investigated considering that bacterial infection in fibroblasts cultures is a very frequent event.
Fernanda Timm Seabra Souza +3 more
doaj +1 more source
Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa
Pseudomonas aeruginosa is an opportunistic nosocomial pathogen associated with high morbidity and mortality rates. Combination of antibiotics has been found to combat multi-drug resistant or extensively drug resistance P. aeruginosa.
Sara Mahmoud Farhan +6 more
doaj +1 more source
We tested 42 strains of amikacin-resistant gram-negative bacilli with amikacin in combination with six beta-lactam antibiotics using the checkerboard and time kill curve techniques.
Berk, Steven L. +3 more
core +1 more source
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia
International audienceBackground: Whether preventive inhaled antibiotics may reduce the incidence of ventilator-associated pneumonia is unclear.Methods: In this investigator-initiated, multicenter, double-blind, randomized, controlled, superiority trial,
Azaïs, Marie-Ange +34 more
core +1 more source
Abstract Objectives Biliary atresia (BA) is a cholangiopathy characterized by obstruction of the intrahepatic and extrahepatic bile ducts. Hepatic portoenterostomy (HPE) is the primary palliative treatment and there is still an urgent need to improve post‐HPE management.
Bianca Ferraz de Almeida Silva +7 more
wiley +1 more source
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley +1 more source
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva +23 more
wiley +1 more source
Antibiogram of Escherichia coli and Klebsiella pneumoniae Urinary Isolates and Susceptibility of Amikacin in Extended-spectrum Beta-Lactamase Producers [PDF]
Urinary tract infections (UTIs) are predominantly caused by bacteria, with Escherichia coli and Klebsiella pneumoniae being predominant causative agents. This retrospective study evaluated the antibiotic susceptibility profiles of E.
Nipa Singh +5 more
core +1 more source
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa [PDF]
South Africa shows one of the highest global burdens of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). Since 2002, MDR-TB in South Africa has been treated by a standardized combination therapy, which until 2010 included
Pillay, Manormoney +41 more
core +2 more sources

